Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Neuroprotective effects of YM-39558, a potential treatment for stroke

July 14, 1998

Antagonists of neurotrophin activity described by Allelix for pain, epilepsy and AD

July 13, 1998

Merck's new tachykinin receptor antagonists useful for pain, inflammation, etc.

July 13, 1998

Cephalon and Medtronic renew ITB copromotion agreement

July 13, 1998

Fentanyl delivery via SmartMist provides effective analgesia

July 13, 1998

GABA-A receptor modulators discovered by NeuroSearch

July 10, 1998

Compounds for dopaminergic disorders discovered at American Home Products

July 9, 1998

Adenosine derivatives useful for CNS and cardiovascular disorders

July 9, 1998

Caspase inhibitors in development at Warner-Lambert

July 9, 1998

RADARS study establishes efficacy and safety of Diastat

July 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...